Adimmune Corp
TWSE:4142

Watchlist Manager
Adimmune Corp Logo
Adimmune Corp
TWSE:4142
Watchlist
Price: 19.75 TWD -0.25% Market Closed
Market Cap: NT$8.5B

Operating Margin

-51.1%
Current
Declining
by 27.1%
vs 3-y average of -24%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-51.1%
=
Operating Income
NT$-613.5m
/
Revenue
NT$1.2B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-51.1%
=
Operating Income
NT$-613.5m
/
Revenue
NT$1.2B

Peer Comparison

Country Company Market Cap Operating
Margin
TW
Adimmune Corp
TWSE:4142
8.3B TWD
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
US
Abbvie Inc
NYSE:ABBV
385.5B USD
Loading...
US
Amgen Inc
NASDAQ:AMGN
186.7B USD
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
162.9B USD
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
118.7B USD
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
79.6B USD
Loading...
AU
CSL Ltd
ASX:CSL
87B AUD
Loading...
NL
argenx SE
XBRU:ARGX
43.1B EUR
Loading...
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
48.8B USD
Loading...

Market Distribution

Lower than 95% of companies in Taiwan
Percentile
5th
Based on 1 045 companies
5th percentile
-51.1%
Low
-21 347.1% — 0.7%
Typical Range
0.7% — 11.5%
High
11.5% — 698%
Distribution Statistics
Taiwan
Min -21 347.1%
30th Percentile 0.7%
Median 5%
70th Percentile 11.5%
Max 698%

Adimmune Corp
Glance View

Market Cap
8.5B TWD
Industry
Biotechnology

ADIMMUNE CORPORATION is a Taiwan-based company principally engaged in the research and development, processing, manufacture and trading of influenza vaccine products and non-flu vaccine products. The Company's products include Japanese encephalitis vaccines, tetanus vaccines, influenza vaccines, H1N1 influenza vaccines and tuberculin. The vaccine products are applied in the prevention of various infectious viruses. The tuberculin is applied in tuberculin purified protein derivative (PPD) test. The Company distributes its products within domestic market and to overseas markets, including other markets in Asia, Europe and Africa.

Intrinsic Value
23.39 TWD
Undervaluation 16%
Intrinsic Value
Price
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-51.1%
=
Operating Income
NT$-613.5m
/
Revenue
NT$1.2B
What is Adimmune Corp's current Operating Margin?

The current Operating Margin for Adimmune Corp is -51.1%, which is below its 3-year median of -24%.

How has Operating Margin changed over time?

Over the last 3 years, Adimmune Corp’s Operating Margin has decreased from 7.6% to -51.1%. During this period, it reached a low of -51.1% on Oct 30, 2025 and a high of 7.6% on Aug 30, 2022.

Back to Top